GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » PEG Ratio

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) PEG Ratio : 1.44 (As of Jun. 02, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Tonghua Dongbao Pharmaceutical Co's PE Ratio without NRI is 15.67. Tonghua Dongbao Pharmaceutical Co's 5-Year EBITDA growth rate is 10.90%. Therefore, Tonghua Dongbao Pharmaceutical Co's PEG Ratio for today is 1.44.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Tonghua Dongbao Pharmaceutical Co's PEG Ratio or its related term are showing as below:

SHSE:600867' s PEG Ratio Range Over the Past 10 Years
Min: 0.58   Med: 1.95   Max: 12.6
Current: 1.44


During the past 13 years, Tonghua Dongbao Pharmaceutical Co's highest PEG Ratio was 12.60. The lowest was 0.58. And the median was 1.95.


SHSE:600867's PEG Ratio is ranked better than
54.03% of 372 companies
in the Drug Manufacturers industry
Industry Median: 1.635 vs SHSE:600867: 1.44

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Tonghua Dongbao Pharmaceutical Co PEG Ratio Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co PEG Ratio Chart

Tonghua Dongbao Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.16 10.13 5.44 1.63 1.76

Tonghua Dongbao Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 2.02 2.08 1.76 1.84

Competitive Comparison of Tonghua Dongbao Pharmaceutical Co's PEG Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Tonghua Dongbao Pharmaceutical Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tonghua Dongbao Pharmaceutical Co's PEG Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tonghua Dongbao Pharmaceutical Co's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Tonghua Dongbao Pharmaceutical Co's PEG Ratio falls into.



Tonghua Dongbao Pharmaceutical Co PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Tonghua Dongbao Pharmaceutical Co's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=15.665529010239/10.90
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Tonghua Dongbao Pharmaceutical Co  (SHSE:600867) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Tonghua Dongbao Pharmaceutical Co PEG Ratio Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Traded in Other Exchanges
N/A
Address
Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
Executives
Cheng Jian Qiu Supervisors
Chang Xiao Hui Director
Li Cong Director
Li Feng Qin Director
Chen Hong senior management
Leng Chun Sheng Director
Li Yi Kui Director
Wang Dian Duo Supervisors
Wang Jun Ye Director
Han Jie Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines